Repeated methamphetamine treatment increases expression of TRPV1 mRNA in the frontal cortex but not in the striatum or hippocampus of mice

Neuroscience Letters

Volumn 472, Issue 1, 2010, Pages 61-64

  Tian, Yu Hua ^a   Lee, Seok Yong ^a   Kim, Hyoung Chun ^b   Jang, Choon Gon ^a  

^a Sungkyunkwan University   (South Korea)

^b Korea Institute of Drug Abuse   (South Korea)

Author keywords

Frontal cortex; Methamphetamine; mRNA; Time course; TRPV1

Indexed keywords

MESSENGER RNA; METHAMPHETAMINE; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; FRONTAL LOBE; HIPPOCAMPUS; METHAMPHETAMINE; MICE; RNA, MESSENGER; TRPV CATION CHANNELS;

EID: 76949093523     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.01.058     Document Type: Article

References (30)

1. Anggadiredja K., Nakamichi M., Hiranita T., Tanaka H., Shoyama Y., Watanabe S., and Yamamoto T. Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade. Neuropsychopharmacology 29 (2004) 1470-1478
2. Blednov Y.A., and Harris R.A. Deletion of vanilloid receptor (TRPV1) in mice alters behavioral effects of ethanol. Neuropharmacology 56 (2009) 814-820
3. Carlton S.M., and Coggeshall R.E. Peripheral capsaicin receptors increase in the inflamed rat hindpaw: a possible mechanism for peripheral sensitization. Neurosci. Lett. 310 (2001) 53-56
4. Carlton S.M., and Hargett G.L. Stereological analysis of Ca(2+)/calmodulin-dependent protein kinase II alpha-containing dorsal root ganglion neurons in the rat: colocalization with isolectin Griffonia simplicifolia, calcitonin gene-related peptide, or vanilloid receptor 1. J. Comp. Neurol. 448 (2002) 102-110
5. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
6. Chen Y., Geis C., and Sommer C. Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway. J. Neurosci. 28 (2008) 5836-5845
7. Chiang Y.C., and Chen J.C. The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats. J. Neurochem. 103 (2007) 2505-2517
8. Hayase T., Yamamoto Y., and Yamamoto K. Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. Behav. Pharmacol. 16 (2005) 395-404
9. Hiranita T., Nawata Y., Sakimura K., and Yamamoto T. Methamphetamine-seeking behavior is due to inhibition of nicotinic cholinergic transmission by activation of cannabinoid CB1 receptors. Neuropharmacology 55 (2008) 1300-1306
10. Jedynak J.P., Uslaner J.M., Esteban J.A., and Robinson T.E. Methamphetamine-induced structural plasticity in the dorsal striatum. Eur. J. Neurosci. 25 (2007) 847-853
11. Ji R.R., Samad T.A., Jin S.X., Schmoll R., and Woolf C.J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36 (2002) 57-68
12. Kerdsan W., Thanoi S., and Nudmamud-Thanoi S. Changes in glutamate/NMDA receptor subunit 1 expression in rat brain after acute and subacute exposure to methamphetamine. J. Biomed. Biotechnol. 2009 (2009) 329631
13. Khairatkar-Joshi N., and Szallasi A. TRPV1 antagonists: the challenges for therapeutic targeting. Trends Mol. Med. 15 (2009) 14-22
14. Kim H.S., Jang C.G., Park W.K., Oh K.W., Rheu H.M., Cho D.H., and Oh S. Blockade by ginseng total saponin of methamphetamine-induced hyperactivity and conditioned place preference in mice. Gen. Pharmacol. 27 (1996) 199-204
15. Kim S.R., Lee D.Y., Chung E.S., Oh U.T., Kim S.U., and Jin B.K. Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. J. Neurosci. 25 (2005) 662-671
16. Landa L., Sulcova A., and Slais K. Involvement of cannabinoid CB1 and CB2 receptor activity in the development of behavioural sensitization to methamphetamine effects in mice. Neuro. Endocrinol. Lett. 27 (2006) 63-69
17. Lee K.W., Tian Y.H., You I.J., Kwon S.H., Ha R.R., Lee S.Y., Kim H.C., and Jang C.G. Blockade of M1 muscarinic acetylcholine receptors modulates the methamphetamine-induced psychomotor stimulant effect. Neuroscience 153 (2008) 1235-1244
18. Ma W., and Quirion R. Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin. Therap. Targets 11 (2007) 307-320
19. Maehara S., Hikichi H., Satow A., Okuda S., and Ohta H. Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia. Pharmacol. Biochem. Behav. 91 (2008) 140-149
20. Mahmud A., Santha P., Paule C.C., and Nagy I. Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons. Neuroscience 162 (2009) 1202-1211
21. Mezey E., Toth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., and Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3655-3660
22. Nagai T., Noda Y., Ishikawa K., Miyamoto Y., Yoshimura M., Ito M., Takayanagi M., Takuma K., Yamada K., and Nabeshima T. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization. J. Neurochem. 92 (2005) 660-667
23. Niwa M., Nitta A., Mizoguchi H., Ito Y., Noda Y., Nagai T., and Nabeshima T. A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference. J. Neurosci. 27 (2007) 7604-7615
24. Sharkey K.A., Cristino L., Oland L.D., Van Sickle M.D., Starowicz K., Pittman Q.J., Guglielmotti V., Davison J.S., and Di Marzo V. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Eur. J. Neurosci. 25 (2007) 2773-2782
25. Simoes P.F., Silva A.P., Pereira F.C., Marques E., Milhazes N., Borges F., Ribeiro C.F., and Macedo T.R. Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex. Ann. N. Y. Acad. Sci. 1139 (2008) 232-241
26. Smith K.J., Butler T.R., Self R.L., Braden B.B., and Prendergast M.A. Potentiation of N-methyl-d-aspartate receptor-mediated neuronal injury during methamphetamine withdrawal in vitro requires co-activation of IP3 receptors. Brain Res. 1187 (2008) 67-73
27. Toth A., Boczan J., Kedei N., Lizanecz E., Bagi Z., Papp Z., Edes I., Csiba L., and Blumberg P.M. Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res. Mol. Brain Res. 135 (2005) 162-168
28. Yoo J.H., Cho J.H., Yu H.S., Lee K.W., Lee B.H., Jeong S.M., Nah S.Y., Kim H.C., Lee S.Y., and Jang C.G. Involvement of 5-HT3 receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT3A receptor channel and binding study. J. Neurochem. 99 (2006) 976-988
29. Yu L.L., Wang X.Y., Zhao M., Liu Y., Li Y.Q., Li F.Q., Wang X., Xue Y.X., and Lu L. Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice. Psychopharmacology (Berl.) 204 (2009) 203-211
30. Zhuang Z.Y., Xu H., Clapham D.E., and Ji R.R. Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J. Neurosci. 24 (2004) 8300-8309